Showing results (721-730 of 927) with videos related to

Sort By:
Pageof 93
Shock (Augusta, Ga.)|July 9, 2021
Incidence, Clinical Characteristics and Outcomes of Early Hyperbilirubinemia in Critically Ill Patients: Insights From the MARS StudyJenny Juschten, Lieuwe D J Bos, Harm-Jan de Grooth, et al.
Critical Care (London, England)|November 26, 2015
Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patientsArie J Hoogendijk, Maryse A Wiewel, Lonneke A van Vught, et al.
Frontiers in Immunology|May 31, 2021
Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 PatientsEsther J Nossent, Alex R Schuurman, Tom D Y Reijnders, et al.
Thorax|May 4, 2023
Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortalityJustin de Brabander, Leonoor S Boers, Robert F J Kullberg, et al.
Intensive Care Medicine Experimental|July 29, 2015
The receptor for advanced glycation end products in ventilator-induced lung injuryMaria T Kuipers, Hamid Aslami, Pieter Roel Tuinman, et al.
Plos One|February 13, 2016
The Impact of HIV Co-Infection on the Genomic Response to SepsisMichaëla A M Huson, Brendon P Scicluna, Lonneke A van Vught, et al.
Eclinicalmedicine|October 6, 2021
Rectal bacteriome and virome signatures and clinical outcomes in community-acquired pneumonia: An exploratory studyRobert F J Kullberg, Floor Hugenholtz, Xanthe Brands, et al.
Critical Care Medicine|May 3, 2021
Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired PneumoniaXanthe Brands, Floris M C de Vries, Fabrice Uhel, et al.
Critical Care (London, England)|July 15, 2020
The circular RNA landscape in specific peripheral blood mononuclear cells of critically ill patients with sepsisHina N Khan, Xanthe Brands, Simona Aufiero, et al.
Pageof 93